Literature DB >> 21912757

Canadian guidelines for colorectal cancer screening.

Jennifer J Telford1.   

Abstract

Decisions regarding colorectal cancer screening will continue to depend on local resources, which in some jurisdictions includes programmatic screening and individual patient preferences. I encourage gastroenterologists to participate in programmatic screening and assist in developing the colonoscopy quality assurance and improvement programs. Our involvement would ensure that we remain leaders in this area and that our expertise in quality in endoscopy is recognized. Finally, participation in programmatic screening should benefit endoscopic services by increasing resources to support higher colonoscopy volumes, shorter wait lists and continuing quality assurance.

Entities:  

Mesh:

Year:  2011        PMID: 21912757      PMCID: PMC3202353          DOI: 10.1155/2011/285926

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  32 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  A comparison of self-reported colorectal cancer screening with medical records.

Authors:  Lisa Madlensky; John McLaughlin; Vivek Goel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-07       Impact factor: 4.254

3.  Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening.

Authors:  Desmond Leddin; Richard Hunt; Malcolm Champion; Alan Cockeram; Nigel Flook; Michael Gould; Young-In Kim; Jonathan Love; David Morgan; Susan Natsheh; Dan Sadowski
Journal:  Can J Gastroenterol       Date:  2004-02       Impact factor: 3.522

4.  Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.

Authors:  D P Berry; P Clarke; J D Hardcastle; K D Vellacott
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

5.  Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010.

Authors:  Desmond J Leddin; Robert Enns; Robert Hilsden; Victor Plourde; Linda Rabeneck; Daniel C Sadowski; Harminder Signh
Journal:  Can J Gastroenterol       Date:  2010-12       Impact factor: 3.522

6.  A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.

Authors:  O D Jørgensen; O Kronborg; C Fenger
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

8.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

9.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

10.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  7 in total

1.  Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.

Authors:  Maida J Sewitch; Mengzhu Jiang; Roland Grad; Mark Yaffe; Alan Pavilanis; Lawrence Joseph; Alan N Barkun; Mark Roper
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

2.  Geographic variation in the provider of screening colonoscopy in Canada: a population-based cohort study.

Authors:  Aristithes G Doumouras; Sama Anvari; Margherita Cadeddu; Mehran Anvari; Dennis Hong
Journal:  CMAJ Open       Date:  2018-03-13

3.  Quality audit of colonoscopy reports amongst patients screened or surveilled for colorectal neoplasia.

Authors:  Daphnée Beaulieu; Alan Barkun; Myriam Martel
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

4.  Report on the expert forum on using information technology to facilitate uptake and impact of colorectal cancer screening guidelines.

Authors:  Maida J Sewitch; Mengzhu Jiang; Alan N Barkun; David Armstrong; Donna Manca; Peter Rossos; Barry Stein; Meeting Attendees
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

5.  Qualitative study of physician perspectives on classifying screening and nonscreening colonoscopy using administrative health data: adding practice does not make perfect.

Authors:  Maida J Sewitch; Robert Hilsden; Lawrence Joseph; Linda Rabineck; Lawrence Paszat; Alain Bitton; Mary Anne Cooper
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

6.  Use of Simulation Modeling to Inform Decision Making for Health Care Systems and Policy in Colorectal Cancer Screening: Protocol for a Systematic Review.

Authors:  Heather Smith; Peyman Varshoei; Robin Boushey; Craig Kuziemsky
Journal:  JMIR Res Protoc       Date:  2020-05-13

7.  Endoscopist specialty is associated with colonoscopy quality.

Authors:  Mengzhu Jiang; Maida J Sewitch; Alan N Barkun; Lawrence Joseph; Robert J Hilsden
Journal:  BMC Gastroenterol       Date:  2013-05-03       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.